| Sangamo Therapeutics (SGMO) | |||
|---|---|---|---|
| 5.29 0.09 (1.73%) | 08-08 16:00 | ||
| Open: | 5.23 | Pre. Close: | 5.2 |
| High: | 5.355 | Low: | 5.121 |
| Volume: | 1,416,411 | Market Cap: | 828M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 5.367 - 5.387 | 5.387 - 5.403 |
| Low: | 5.067 - 5.092 | 5.092 - 5.112 |
| Close: | 5.252 - 5.291 | 5.291 - 5.322 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 6.25  One year: 7.31 |
| Support: | Support1: 4.61 Support2: 4.15 |
| Resistance: | Resistance1: 5.36 Resistance2: 6.25 |
| Pivot: | 4.64 |
| Moving Averages: | MA(5): 4.90 MA(20): 4.61 MA(100): 4.53  MA(250): 6.57 |
| MACD: | MACD(12,26): 0.17 Signal(12,26,9): 0.11 |
| %K %D: | %K(14,3): 85.60 %D(3): 72.55 |
| RSI: | RSI(14): 70.09 |
| 52-Week: | High: 11.49 Low: 3.12 Change(%): -44.5 |
| Average Vol(K): | 3-Month: 1798 10-Days: 1427 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SGMO ] has closed above the upper band by 6.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 1.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Global Select | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | 146.69 |
| Shares Float (M) | 121.99 |
| % Held by Insiders | 16.91 |
| % Held by Institutions | 55.72 |
| Shares Short (K) | 10320 |
| Shares Short Prior Month (K) | 10500 |
| Stock Financials | |
|---|---|
| EPS | -1.210 |
| Book Value (p.s.) | 2.280 |
| Profit Margin | -156.53 |
| Operating Margin | -161.82 |
| Return on Assets (ttm) | -14.9 |
| Return on Equity (ttm) | -43.9 |
| Qtrly Rev. Growth | 7.4 |
| Gross Profit (p.s.) | -0.819 |
| Sales Per Share | 0.768 |
| EBITDA (p.s.) | -1.172 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -223.68 |
| Levered Free Cash Flow (M) | -93.14 |
| Stock Valuation | |
|---|---|
| PE Ratio | -4.37 |
| PEG Ratio | |
| Price to Book value | 2.32 |
| Price to Sales | 6.89 |
| Price to Cash Flow | -3.47 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
